scholarly journals Additional Benefits of Home Blood Pressure Monitors

Hypertension ◽  
2009 ◽  
Vol 53 (4) ◽  
Author(s):  
Robert A. Murden ◽  
Christina Stamoolis
Author(s):  
Isis Chong ◽  
Jackie Cha ◽  
Frank Peng ◽  
Denny Yu

Although advancements in home-use technologies have allowed users to take control over how they monitor their health, their likely inexperience with such technologies can lead to use errors. The study aimed to determine the usability of a home-use blood pressure monitor, which included the device and instructional materials. Nineteen participants completed a 45-minute study which included an out-of-the-box handling scenario without moderator facilitation. The primary goal of this scenario was to determine if participants would be able to classify their heart rate reading obtained from the heart rate monitor as either low, average, or high in accordance to the thresholds set by the device. Although a majority of users were able to complete the use scenario, users nonetheless experienced major use errors and had difficulty with correctly placing the blood pressure cuff on their arm or inadvertently inflated the cuff when simply trying to turn on the device. There were also differences in the instructional materials such as how users should place the cuff around their arm. These inconsistencies were exacerbated by ambiguous wording without any pictorial clarifications. Additionally, 10% of users were unable to locate information on how to interpret their blood pressure readings. These findings highlight the importance of studying the usability of at-home blood pressure monitors to ensure more accurate health monitoring of users.


Author(s):  
Thineskrishna Anbarasan ◽  
Amy Rogers ◽  
David A. Rorie ◽  
J. W. Kerr Grieve ◽  
Thomas M. MacDonald ◽  
...  

AbstractVarious home blood pressure monitors (HBPMs) are available to the public for purchase but only some are validated against standardised protocols. This study aimed to assess whether HBPMs owned by participants taking part in a clinical trial were validated models. The TIME study is a decentralised randomised trial investigating the effect of antihypertensive medication dosing time on cardiovascular outcomes in adults with hypertension. No HBPMs were provided to participants in this trial but patients were asked to report if they already owned one. We identified the model of HBPM reported by participants, then cross-referenced this against lists of validated HBPMs produced by dabl Educational Trust and the British and Irish Hypertension Society (BIHS). Of 21,104 participants, 10,464 (49.6%) reported their model of HBPM. 7464 (71.3%) of these participants owned a monitor that could be identified from the participants’ entry. Of these, 6066 (81.3%) participants owned a monitor listed as validated by either dabl (n = 5903) or BIHS (n = 5491). Some were listed as validated by both. 1398 (18.7%) participants owned an identifiable HBPM that lacked clear evidence of validation. 6963 (93.3%) participants owned an upper arm HBPM and 501 (6.7%) owned a wrist HBPM. Validated HBPMs had a higher median online retail price of £45.00 compared to £20.00 for HBPMs lacking clear evidence of validation. A significant number of participants own HBPMs lacking evidence of validation.


Sign in / Sign up

Export Citation Format

Share Document